Transform how you analyse drug development risk
With the only transparent analysis of drug development risk at the product level.
Worldwide prescription drugs sales predicted to reach $1.18trn in 2024, with a compound annual growth of 6.9%, significantly higher than the 1.7% CAGR between 2011-2018.
The latest annual World Preview 2019, Outlook to 2024 comes at one of the most exciting points in the industry’s development. There is significant optimism around the launch of new technologies and the approval of the first cell and gene therapies, resulting in prescription drug sales being forecast to reach $1.18trn in 2024.